Recent FDA guidance aims to improve research inclusivity and the generalizability of clinical findings by ensuring diverse participant representation — it’s about better science, improved patient outcomes, and equitable healthcare access.
The post Patient-Centricity is Reliant on Representative Clinical Studies appeared first on MedCity News.
